Who Paid My Doc
BI 1015550 - Ph3 Open Label Extension
Research payments
$1,080,571
Through program year 2025, $1,080,571 in research payments was reported against BI 1015550 - Ph3 Open Label Extension, across 131 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,000 | 1 |
| 2024 | Research | $1,079,571 | 130 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mary Kreider Philadelphia, PA Named on 4 payments
- Jamie Sheth Ann Arbor, MI Named on 4 payments
- Amy Case Austell, GA Named on 3 payments
- Hyun Kim Minneapolis, MN Named on 3 payments
- Gerard Criner Philadelphia, PA Named on 3 payments
- David Hotchkin Portland, OR Named on 3 payments
- Tanzira Zaman West Hollywood, CA Named on 3 payments
- Reginald Fowler Winston-Salem, NC Named on 3 payments
- Christopher Harden Gainesville, FL Named on 3 payments
- Stephen Samuel Weigt Los Angeles, CA Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.